The role of brain-derived neurotrophic factor in bone marrow stromal cell-mediated spinal cord repair

Gaby J. Ritfeld, Ajay Patel, Alexander Chou, Tabitha L. Novosat, Deborah G. Castillo, Raymund A C Roos, Martin Oudega

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The ability of intraspinal bone marrow stromal cell (BMSC) transplants to elicit repair is thought to result from paracrine effects by secreted trophic factors including brain-derived neurotrophic factor (BDNF). Here we used gene therapy to increase or silence BDNF production in BMSCs to investigate the role of BDNF in BMSC-mediated neuroprotection. In a spinal cord organotypic culture, BMSC-conditioned medium significantly enhanced spinal motoneuron survival by 64% compared with culture medium only. Only conditioned medium of BDNF-hypersecreting BMSCs sustained this neuroprotective effect. In a rat model of spinal cord contusion, a BDNF-dependent neuroprotective effect was confirmed; only with a subacute transplant of BDNFhypersecreting BMSCs were significantly more spared motoneurons found at 4 weeks postinjury compared with vehicle controls. Spared nervous tissue volume was improved by 68% with both control BMSCs and BDNF-hypersecreting BMSCs. In addition, blood vessel density in the contusion with BDNF-hypersecreting BMSCs was 35% higher compared with BMSC controls and sixfold higher compared with vehicle controls. BDNF-silenced BMSCs did not survive the first week of transplantation, and no neuroprotective effect was found at 4 weeks after transplantation. Together, our data broaden our understanding of the role of BDNF in BMSC-mediated neuroprotection and successfully exploit BDNF dependency to enhance anatomical spinal cord repair.

Original languageEnglish (US)
Pages (from-to)2209-2220
Number of pages12
JournalCell Transplantation
Volume24
Issue number11
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Spinal Cord Regeneration
Brain-Derived Neurotrophic Factor
Mesenchymal Stromal Cells
Brain
Bone
Repair
Neuroprotective Agents
Transplants
Motor Neurons
Conditioned Culture Medium
Transplantation
Nerve Growth Factors
Nerve Tissue
Gene therapy
Contusions
Blood vessels
Spinal Cord Injuries
Genetic Therapy
Blood Vessels
Culture Media

Keywords

  • Blood vessels
  • Bone marrow stromal cells (BMSCs)
  • Brain-derived neurotrophic factor (BDNF)
  • Gene therapy
  • Neuroprotection
  • Spinal cord injury

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

The role of brain-derived neurotrophic factor in bone marrow stromal cell-mediated spinal cord repair. / Ritfeld, Gaby J.; Patel, Ajay; Chou, Alexander; Novosat, Tabitha L.; Castillo, Deborah G.; Roos, Raymund A C; Oudega, Martin.

In: Cell Transplantation, Vol. 24, No. 11, 2015, p. 2209-2220.

Research output: Contribution to journalArticle

Ritfeld, Gaby J. ; Patel, Ajay ; Chou, Alexander ; Novosat, Tabitha L. ; Castillo, Deborah G. ; Roos, Raymund A C ; Oudega, Martin. / The role of brain-derived neurotrophic factor in bone marrow stromal cell-mediated spinal cord repair. In: Cell Transplantation. 2015 ; Vol. 24, No. 11. pp. 2209-2220.
@article{47eaa1d231604515bb170cc51d6c6175,
title = "The role of brain-derived neurotrophic factor in bone marrow stromal cell-mediated spinal cord repair",
abstract = "The ability of intraspinal bone marrow stromal cell (BMSC) transplants to elicit repair is thought to result from paracrine effects by secreted trophic factors including brain-derived neurotrophic factor (BDNF). Here we used gene therapy to increase or silence BDNF production in BMSCs to investigate the role of BDNF in BMSC-mediated neuroprotection. In a spinal cord organotypic culture, BMSC-conditioned medium significantly enhanced spinal motoneuron survival by 64{\%} compared with culture medium only. Only conditioned medium of BDNF-hypersecreting BMSCs sustained this neuroprotective effect. In a rat model of spinal cord contusion, a BDNF-dependent neuroprotective effect was confirmed; only with a subacute transplant of BDNFhypersecreting BMSCs were significantly more spared motoneurons found at 4 weeks postinjury compared with vehicle controls. Spared nervous tissue volume was improved by 68{\%} with both control BMSCs and BDNF-hypersecreting BMSCs. In addition, blood vessel density in the contusion with BDNF-hypersecreting BMSCs was 35{\%} higher compared with BMSC controls and sixfold higher compared with vehicle controls. BDNF-silenced BMSCs did not survive the first week of transplantation, and no neuroprotective effect was found at 4 weeks after transplantation. Together, our data broaden our understanding of the role of BDNF in BMSC-mediated neuroprotection and successfully exploit BDNF dependency to enhance anatomical spinal cord repair.",
keywords = "Blood vessels, Bone marrow stromal cells (BMSCs), Brain-derived neurotrophic factor (BDNF), Gene therapy, Neuroprotection, Spinal cord injury",
author = "Ritfeld, {Gaby J.} and Ajay Patel and Alexander Chou and Novosat, {Tabitha L.} and Castillo, {Deborah G.} and Roos, {Raymund A C} and Martin Oudega",
year = "2015",
doi = "10.3727/096368915X686201",
language = "English (US)",
volume = "24",
pages = "2209--2220",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "11",

}

TY - JOUR

T1 - The role of brain-derived neurotrophic factor in bone marrow stromal cell-mediated spinal cord repair

AU - Ritfeld, Gaby J.

AU - Patel, Ajay

AU - Chou, Alexander

AU - Novosat, Tabitha L.

AU - Castillo, Deborah G.

AU - Roos, Raymund A C

AU - Oudega, Martin

PY - 2015

Y1 - 2015

N2 - The ability of intraspinal bone marrow stromal cell (BMSC) transplants to elicit repair is thought to result from paracrine effects by secreted trophic factors including brain-derived neurotrophic factor (BDNF). Here we used gene therapy to increase or silence BDNF production in BMSCs to investigate the role of BDNF in BMSC-mediated neuroprotection. In a spinal cord organotypic culture, BMSC-conditioned medium significantly enhanced spinal motoneuron survival by 64% compared with culture medium only. Only conditioned medium of BDNF-hypersecreting BMSCs sustained this neuroprotective effect. In a rat model of spinal cord contusion, a BDNF-dependent neuroprotective effect was confirmed; only with a subacute transplant of BDNFhypersecreting BMSCs were significantly more spared motoneurons found at 4 weeks postinjury compared with vehicle controls. Spared nervous tissue volume was improved by 68% with both control BMSCs and BDNF-hypersecreting BMSCs. In addition, blood vessel density in the contusion with BDNF-hypersecreting BMSCs was 35% higher compared with BMSC controls and sixfold higher compared with vehicle controls. BDNF-silenced BMSCs did not survive the first week of transplantation, and no neuroprotective effect was found at 4 weeks after transplantation. Together, our data broaden our understanding of the role of BDNF in BMSC-mediated neuroprotection and successfully exploit BDNF dependency to enhance anatomical spinal cord repair.

AB - The ability of intraspinal bone marrow stromal cell (BMSC) transplants to elicit repair is thought to result from paracrine effects by secreted trophic factors including brain-derived neurotrophic factor (BDNF). Here we used gene therapy to increase or silence BDNF production in BMSCs to investigate the role of BDNF in BMSC-mediated neuroprotection. In a spinal cord organotypic culture, BMSC-conditioned medium significantly enhanced spinal motoneuron survival by 64% compared with culture medium only. Only conditioned medium of BDNF-hypersecreting BMSCs sustained this neuroprotective effect. In a rat model of spinal cord contusion, a BDNF-dependent neuroprotective effect was confirmed; only with a subacute transplant of BDNFhypersecreting BMSCs were significantly more spared motoneurons found at 4 weeks postinjury compared with vehicle controls. Spared nervous tissue volume was improved by 68% with both control BMSCs and BDNF-hypersecreting BMSCs. In addition, blood vessel density in the contusion with BDNF-hypersecreting BMSCs was 35% higher compared with BMSC controls and sixfold higher compared with vehicle controls. BDNF-silenced BMSCs did not survive the first week of transplantation, and no neuroprotective effect was found at 4 weeks after transplantation. Together, our data broaden our understanding of the role of BDNF in BMSC-mediated neuroprotection and successfully exploit BDNF dependency to enhance anatomical spinal cord repair.

KW - Blood vessels

KW - Bone marrow stromal cells (BMSCs)

KW - Brain-derived neurotrophic factor (BDNF)

KW - Gene therapy

KW - Neuroprotection

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=84945955734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945955734&partnerID=8YFLogxK

U2 - 10.3727/096368915X686201

DO - 10.3727/096368915X686201

M3 - Article

C2 - 25581479

AN - SCOPUS:84945955734

VL - 24

SP - 2209

EP - 2220

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 11

ER -